• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24124 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Re-use of medical devices
2017     NIHR Health Services and Delivery Research programme REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
2016     NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Real-time (synchronous) telehealth in primary care: systematic review of systematic reviews
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2009     Medical Services Advisory Committee (MSAC) Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2017     NIHR Health Technology Assessment programme Real-time modelling of a pandemic influenza outbreak
2024     NIHR Health and Social Care Delivery Program Real-time ultrasound elastography in the diagnosis of newly identified thyroid nodules in adults: the ElaTION RCT
2021     Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2011     NIHR Horizon Scanning Centre (NIHR HSC) RealTime mS9 Colorectal Cancer (CRC) assay for the early detection of colorectal cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Rebetron - hepatitis C
2025     NIHR Health Technology Assessment programme Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Receptor-imaging somatotropine inhibitor factor analogue in endocrine oncology - primary research
2009     HAYES, Inc. Reclast (Novartis Pharmaceuticals Corp.) for bone loss prevention during breast cancer chemotherapy
2015     University of York Recognising and managing frailty in primary care
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2002     University HealthSystem Consortium (UHC) Recombinant antihemophilic factor VIII
2022     Agency for Care Effectiveness (ACE) Recombinant blood products for prophylaxis and management of haemophilia A and B
2010     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant coagulation factor VIIa (rFVIIa) for treatment of bleeding and transient normalization of inr in patients on warfarin anticoagulation
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for prevention and treatment of bleeding in patients with underlying disease - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) in intracerebral haemorrhage (ICH) - horizon scanning review
2009     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant factor VIIa for cardiovascular surgery
2002     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa in haemostatis - horizon scanning review
2002     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2003     HAYES, Inc. Recombinant growth hormone treatment for burns, surgery, and critical illness
2003     HAYES, Inc. Recombinant growth hormone treatment for obesity
2003     HAYES, Inc. Recombinant growth hormone treatment in children
2002     HAYES, Inc. Recombinant growth hormone treatment in growth hormone-deficient adults
2014     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human alpha-mannosidase (Lamazym) for alpha mannosidosis
2014     HAYES, Inc. Recombinant human bone morphogenetic protein (rhBMP) for use in spinal fusion
2004     HAYES, Inc. Recombinant human bone morphogenetic protein for use in bone repair
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2001     Blue Cross Blue Shield Association (BCBS) Recombinant human growth hormone (GH) therapy in adults with age-related GH deficiency
1998     ECRI Recombinant human growth hormone for AIDS wasting
2010     NIHR Health Technology Assessment programme Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
2000     ECRI Recombinant human growth hormone for the treatment of idiopathic short stature
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
2013     HAYES, Inc. Recombinant human growth hormone treatment in children under 2 years of age
2012     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2005     ECRI Recombinant human osteogenic protein-1 [rhOP-1] for healing nonunion fractures of the tibia
2020     National Institute for Health and Care Excellence (NICE) Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal). NICE technology appraisal guidance 625
2002     Medical Services Advisory Committee (MSAC) Recombinant human thyroid-stimulating hormone (rhTSH). Diagnostic agent for use in well-differentiated thyroid cancer
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke
2024     Agency for Care Effectiveness (ACE) Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia
2000     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Recombinant-FSH as adjuvant in assisted reproduction: some data on the efficacy and efficiency of recombinant-FSH related to FSH of urinary origin
2006     Institute for Clinical Evaluative Sciences (ICES) Recommendations for establishing a citizens' council to guide drug policy in Ontario
1997     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Recommendations for medical record of the home care patients for ambulatory nursing professionals
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Recommendations for the use of troponin assays for rapid diagnosis of acute coronary syndrome in the emergency department
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reconciliation of data from differing electronic medical records
1999     Health Council of the Netherlands Gezondheidsraad (GR) Reconsidering the policy for HIV testing
2007     NIHR Health Technology Assessment programme Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study
2017     The Regional Health Technology Assessment Centre (HTA-centrum) Rectal cancer with complete clinical remission after chemoradiotherapy: resection or watch-and-wait?
2012     Agency for Healthcare Research and Quality (AHRQ) Recurrent nephrolithiasis in adults: comparative effectiveness of preventive medical strategies
1993     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Red blood cell transfusion - consensus conference
1997     University HealthSystem Consortium (UHC) Red blood cell transfusion guidelines
2003     NIHR Health Technology Assessment programme Redesigning postnatal care: a randomised controlled trial of protocol-based midwifery-led care focused on individual women's physical and psychological health needs
2014     NIHR Horizon Scanning Centre (NIHR HSC) Reducer stent for refractory angina
2013     NIHR Public Health Research (PHR) programme Reducing alcohol-related harm in disadvantaged men: development and feasibility assessment of a brief intervention delivered by mobile telephone
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing AMI readmissions
2021     NIHR Health Technology Assessment programme Reducing bias in trials from reactions to measurement: the MERIT study including developmental work and expert workshop
2014     NIHR Health Services and Delivery Research programme Reducing Care Utilisation through Self-management Interventions (RECURSIVE): a systematic review and meta-analysis
2024     NIHR Health Services and Delivery Research programme Reducing health inequalities through general practice: a realist review and action framework
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing heart failure readmissions
1997     Health Services Utilization and Research Commission (HSURC) Reducing non-urgent use of the emergency department: a review of strategies and guide for future research
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing pneumonia readmissions
2024     NIHR Health Technology Assessment programme Reducing self-harm in adolescents: the RISA-IPD individual patient data meta-analysis and systematic review
1999     Wessex Institute for Health Research and Development (WIHRD) Reducing the interval for diabetic retinal screening
2020     National Institute for Health and Care Excellence (NICE) Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues. NICE interventional procedures guidance 666
2023     NIHR Health Services and Delivery Research programme Reducing unplanned hospital admissions from care homes: a systematic review
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Reduction in length of treatment in respiratory infections - primary research
2008     HAYES, Inc. Reduction mammoplasty
2001     Danish Institute for Health Services Research (DSI) Reduction of the delay in the thrombolysis treatment of patients with acute myocardial infarction. A health economic model-analysis. DSI rapport 2001.07
2021     Health Information and Quality Authority (HIQA) Reduction of the minimum age for the application of mask wearing requirements and recommendations – updated advice
2001     Agency for Healthcare Research and Quality (AHRQ) Refinement of the HCUP quality indicators
1998     Alberta Heritage Foundation for Medical Research (AHFMR) Reflex sympathetic dystrophy
1997     Danish Institute for Health Services Research (DSI) Reforming the health services in the Baltic countries
1993     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Refractive laser surgery
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Refractive laser surgery for vision conditions
2005     Haute Autorite de sante (HAS) Refractory obsessive compulsive disorders: conventional treatments and deep brain stimulation
2020     Malaysian Health Technology Assessment (MaHTAS) Refurbished medical device
2019     NIHR Health Technology Assessment programme Refusal and resistance to care by people living with dementia being cared for within acute hospital wards: an ethnographic study
2012     Belgian Health Care Knowledge Centre (KCE) Regional differences in thyroid cancer incidence in Belgium: role of diagnostic and therapeutic strategies for thyroid disease
2019     European Network for Health Technology Assessment (EUnetHTA) Regional hyperthermia for high-risk soft tissue sarcoma treatment
2012     Institute for Clinical Evaluative Sciences (ICES) Regional measures of diabetes burden in Ontario
2004     Agency for Healthcare Research and Quality (AHRQ) Regionalization of bioterrorism preparedness and response
2009     VA Technology Assessment Program (VATAP) Regionalization of surgical services
2001     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Register of health technology equipments in Catalonia (updated until 31 October 2000) - primary research
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Register of health technology equipments in Catalonia (updated up to 31 October 2004)
2007     Agency for Healthcare Research and Quality (AHRQ) Registries for evaluating patient outcomes: a user's guide
2012     Agency for Healthcare Research and Quality (AHRQ) Registry of patient registries (RoPR): policies and procedures
2011     Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian stroke network - report on the 2008/09 Ontario stroke audit